rs3771475
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_003236.4(TGFA):c.40+11532A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.121 in 152,140 control chromosomes in the GnomAD database, including 1,491 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.12 ( 1491 hom., cov: 32)
Consequence
TGFA
NM_003236.4 intron
NM_003236.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.266
Publications
6 publications found
Genes affected
TGFA (HGNC:11765): (transforming growth factor alpha) This gene encodes a growth factor that is a ligand for the epidermal growth factor receptor, which activates a signaling pathway for cell proliferation, differentiation and development. This protein may act as either a transmembrane-bound ligand or a soluble ligand. This gene has been associated with many types of cancers, and it may also be involved in some cases of cleft lip/palate. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]
TGFA Gene-Disease associations (from GenCC):
- tooth agenesisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.28 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TGFA | NM_003236.4 | c.40+11532A>G | intron_variant | Intron 1 of 5 | ENST00000295400.11 | NP_003227.1 | ||
TGFA | NM_001308158.2 | c.58+10988A>G | intron_variant | Intron 1 of 5 | NP_001295087.1 | |||
TGFA | NM_001308159.2 | c.58+10988A>G | intron_variant | Intron 1 of 5 | NP_001295088.1 | |||
TGFA | NM_001099691.3 | c.40+11532A>G | intron_variant | Intron 1 of 5 | NP_001093161.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.121 AC: 18390AN: 152022Hom.: 1484 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
18390
AN:
152022
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.121 AC: 18401AN: 152140Hom.: 1491 Cov.: 32 AF XY: 0.129 AC XY: 9608AN XY: 74378 show subpopulations
GnomAD4 genome
AF:
AC:
18401
AN:
152140
Hom.:
Cov.:
32
AF XY:
AC XY:
9608
AN XY:
74378
show subpopulations
African (AFR)
AF:
AC:
2353
AN:
41522
American (AMR)
AF:
AC:
3685
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
AC:
549
AN:
3464
East Asian (EAS)
AF:
AC:
1313
AN:
5162
South Asian (SAS)
AF:
AC:
1409
AN:
4818
European-Finnish (FIN)
AF:
AC:
1469
AN:
10582
Middle Eastern (MID)
AF:
AC:
37
AN:
294
European-Non Finnish (NFE)
AF:
AC:
7207
AN:
68006
Other (OTH)
AF:
AC:
271
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
777
1554
2332
3109
3886
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
891
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.